lifestyle.buyersdesire.org

Author: Nxera Pharma

Nxera Pharma Proposes Changes to its Board of Directors

March 10, 2026
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025

March 10, 2026
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals

March 10, 2026
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company

March 10, 2026
Nxera Pharma Webinar Presentation for FY2025 Financial Results

January 26, 2026
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders

January 20, 2026
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

January 19, 2026